Researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other for diagnosed patients who do not require a hospital stay.
Other News
The University of Minnesota is leading a research study that aims to better understand the immune system’s response to COVID-19 vaccines.…
With the news of a COVID-19 outbreak in India and the World Health Organization urging countries to address global inequalities in health,…
As the fight against COVID-19 becomes a charge to quickly vaccinate Minnesotans—especially the most vulnerable—there remain key…